18058241|t|Molecular dynamics studies of alpha-helix stability in fibril-forming peptides.
18058241|a|Diseases associated with protein fibril-formation, such as the prion diseases and Alzheimer's disease, are gaining increased attention due to their medical importance and complex origins. Using molecular dynamics (MD) simulations in an aqueous environment, we have studied the stability of the alpha-helix covering positions 15-25 of the amyloid beta-peptide (A beta) involved in Alzheimer's disease. The effects of residue replacements, including the effects of A beta disease related mutations, were also investigated. The MD simulations show a very early (2 ns) loss of alpha-helical structure for the Flemish (A beta(A21G)), Italian (A beta(E22K)), and Iowa (A beta(D23N)) forms associated with hereditary Alzheimer's disease. Similarly, an early (5 ns) loss of alpha-helical structure was observed for the Dutch (A beta(E22Q)) variant. MD here provides a possible explanation for the structural changes. Two variants of A beta, A beta(K16A,L17A,F20A) and A beta(V18A,F19A,F20A), that do not produce fibrils in vitro were also investigated. The A beta(V18A,F19A,F20A) initially loses its helical conformation but refolds into helix several times and spends most of the simulation time in helical conformation. However, the A beta(K16A,L17A,F20A) loses the alpha-helical structure after 5 ns and does not refold. For the wildtype A beta(1-40) and A beta(1-42), the helical conformation is lost after 5 ns or after 40 ns, respectively, while for the "familial" (A beta(A42T)) variant, the MD simulations suggest that a C-terminal beta-strand is stabilised, which could explain the fibrillation. The simulations for the Arctic (A beta(E22G)) variant indicate that the alpha-helix is kept for 2 ns, but reappears 2 ns later, whereafter it disappears after 10 ns. The MD results are in several cases compatible with known experimental data, but the correlation is not perfect, indicating that multimerisation tendency and other factors might also be important for fibril formation.
18058241	143	157	prion diseases	Disease	MESH:D017096
18058241	162	181	Alzheimer's disease	Disease	MESH:D000544
18058241	440	446	A beta	Gene	351
18058241	460	479	Alzheimer's disease	Disease	MESH:D000544
18058241	543	549	A beta	Gene	351
18058241	694	700	A beta	Gene	351
18058241	701	705	A21G	ProteinMutation	tmVar:p|SUB|A|21|G;HGVS:p.A21G;VariantGroup:1;CorrespondingGene:351;RS#:763852444;CorrespondingSpecies:9606;CA#:9987752
18058241	718	724	A beta	Gene	351
18058241	725	729	E22K	ProteinMutation	tmVar:p|SUB|E|22|K;HGVS:p.E22K;VariantGroup:2;CorrespondingGene:351;CorrespondingSpecies:9606
18058241	743	749	A beta	Gene	351
18058241	750	754	D23N	ProteinMutation	tmVar:p|SUB|D|23|N;HGVS:p.D23N;VariantGroup:0;CorrespondingGene:351;RS#:1297968881;CorrespondingSpecies:9606
18058241	790	809	Alzheimer's disease	Disease	MESH:D000544
18058241	898	904	A beta	Gene	351
18058241	905	909	E22Q	ProteinMutation	tmVar:p|SUB|E|22|Q;HGVS:p.E22Q;VariantGroup:2;CorrespondingGene:351;CorrespondingSpecies:9606
18058241	1005	1011	A beta	Gene	351
18058241	1013	1019	A beta	Gene	351
18058241	1020	1024	K16A	ProteinMutation	tmVar:p|SUB|K|16|A;HGVS:p.K16A;VariantGroup:4;CorrespondingGene:351;CorrespondingSpecies:9606
18058241	1025	1029	L17A	ProteinMutation	tmVar:p|SUB|L|17|A;HGVS:p.L17A;VariantGroup:6;CorrespondingGene:351;CorrespondingSpecies:9606
18058241	1030	1034	F20A	ProteinMutation	tmVar:p|SUB|F|20|A;HGVS:p.F20A;VariantGroup:5;CorrespondingGene:351;CorrespondingSpecies:9606
18058241	1040	1046	A beta	Gene	351
18058241	1047	1051	V18A	ProteinMutation	tmVar:p|SUB|V|18|A;HGVS:p.V18A;VariantGroup:8;CorrespondingGene:351;CorrespondingSpecies:9606
18058241	1052	1056	F19A	ProteinMutation	tmVar:p|SUB|F|19|A;HGVS:p.F19A;VariantGroup:3;CorrespondingGene:351;CorrespondingSpecies:9606
18058241	1057	1061	F20A	ProteinMutation	tmVar:p|SUB|F|20|A;HGVS:p.F20A;VariantGroup:5;CorrespondingGene:351;CorrespondingSpecies:9606
18058241	1129	1135	A beta	Gene	351
18058241	1136	1140	V18A	ProteinMutation	tmVar:p|SUB|V|18|A;HGVS:p.V18A;VariantGroup:8;CorrespondingGene:351;CorrespondingSpecies:9606
18058241	1141	1145	F19A	ProteinMutation	tmVar:p|SUB|F|19|A;HGVS:p.F19A;VariantGroup:3;CorrespondingGene:351;CorrespondingSpecies:9606
18058241	1146	1150	F20A	ProteinMutation	tmVar:p|SUB|F|20|A;HGVS:p.F20A;VariantGroup:5;CorrespondingGene:351;CorrespondingSpecies:9606
18058241	1307	1313	A beta	Gene	351
18058241	1314	1318	K16A	ProteinMutation	tmVar:p|SUB|K|16|A;HGVS:p.K16A;VariantGroup:4;CorrespondingGene:351;CorrespondingSpecies:9606
18058241	1319	1323	L17A	ProteinMutation	tmVar:p|SUB|L|17|A;HGVS:p.L17A;VariantGroup:6;CorrespondingGene:351;CorrespondingSpecies:9606
18058241	1324	1328	F20A	ProteinMutation	tmVar:p|SUB|F|20|A;HGVS:p.F20A;VariantGroup:5;CorrespondingGene:351;CorrespondingSpecies:9606
18058241	1413	1419	A beta	Gene	351
18058241	1430	1436	A beta	Gene	351
18058241	1544	1550	A beta	Gene	351
18058241	1551	1555	A42T	DNAMutation	tmVar:c|SUB|A|42|T;HGVS:c.42A>T;VariantGroup:7;CorrespondingGene:351;CorrespondingSpecies:9606
18058241	1709	1715	A beta	Gene	351
18058241	1716	1720	E22G	ProteinMutation	tmVar:p|SUB|E|22|G;HGVS:p.E22G;VariantGroup:2;CorrespondingGene:351;CorrespondingSpecies:9606
18058241	Positive_Correlation	MESH:D000544	RS#:763852444;HGVS:p.A21G;CorrespondingGene:351
18058241	Positive_Correlation	MESH:D000544	RS#:1297968881;HGVS:p.D23N;CorrespondingGene:351
18058241	Positive_Correlation	MESH:D000544	HGVS:p.E22K;CorrespondingGene:351
18058241	Association	MESH:D000544	351
18058241	Association	MESH:D000544	351

